University of Wisconsin to License their Clinically Developed, Dose-optimized

University of Wisconsin to License their Clinically Developed, Dose-optimized
Today at RSNA 2012, GE Healthcare (NYSE:GE) continued to lead the way in dose-reduction offerings with the announcement of a first-of-its-kind agreement with the University of Wisconsin School of Medicine and Public Health with the purpose of providing …

Full News here – Read more on MarketWatch (press release)

Leave a Reply